Edgestream Partners’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-35,105
Closed -$350K 1010
2024
Q1
$350K Buy
+35,105
New +$350K 0.02% 695